ATLANTA, Jan. 05, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will participate in two investor conference events in January.
Mr. Eiswirth will be presenting at the H.C. Wainwright BioConnect 2022 Virtual Conference. The pre-recorded presentation will be accessible to H.C. Wainwright registered attendees beginning at 7:00 AM ET on Monday, January 10, 2022 – January 13, 2022.
Additionally, Mr. Eiswirth will be hosting one-on-one meetings with registered attendees at Bio One-on-One Partnering @ JPM, January 10, 2022 – January 14, 2022.
About Alimera Sciences, Inc.
Alimera Sciences a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
| For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com |
For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
KENNEWICK, Wash. and HOUSTON, Dec. 11, 2025 /PRNewswire/ -- Cadwell, a global leader in neurodiagnostic…
New embedded solution empowers more than 900,000 small businesses to offer flexible, affordable health coverage directly…
CONSHOHOCKEN, Pa., Dec. 11, 2025 /PRNewswire/ -- Suvoda, a global clinical trial technology company, today announced…
TraceLink announced its support for UNICEF's Traceability and Verification System (TRVST), a global initiative improving…
VISALIA, Calif., Dec. 11, 2025 /PRNewswire/ -- Maison Law Accident & Injury Lawyers announces the…
NASHVILLE, Tenn., Dec. 11, 2025 /PRNewswire/ -- The Tennessee Department of Correction (TDOC) has expanded its…